Elisabet Miró-Casas Selected Research

malonic acid (malonate)

4/2019	Author Correction: Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size.
1/2018	Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size.
3/2016	Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabet Miró-Casas Research Topics

Disease

7	Infarction (Infarctions) 07/2021 - 05/2013
6	Ischemia 07/2021 - 10/2009
3	Coronary Occlusion 07/2021 - 07/2015
3	ST Elevation Myocardial Infarction 07/2021 - 01/2020
3	Reperfusion Injury 01/2018 - 05/2013
3	Hypoxia (Hypoxemia) 09/2012 - 08/2004
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2013 - 11/2007
2	Rupture 10/2009 - 11/2007
1	Iron Deficiencies 07/2021
1	Ventricular Remodeling 07/2021
1	Myocardial Infarction 01/2021
1	Thrombosis (Thrombus) 01/2020
1	Necrosis 11/2007
1	Acidosis 09/2006

Drug/Important Bio-Agent (IBA)

3	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2019 - 03/2016
3	malonic acid (malonate)IBA 04/2019 - 03/2016
2	Exenatide (Byetta)FDA Link 01/2021 - 07/2015
2	Mitochondrial Permeability Transition PoreIBA 03/2016 - 11/2007
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2016 - 10/2009
2	fluorexon (calcein)IBA 10/2009 - 09/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2021
1	IronIBA 07/2021
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 07/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	FibrinIBA 01/2020
1	P-SelectinIBA 01/2020
1	5- (6'- triphenylphosphoniumhexyl)- 5,6- dihydro- 6- phenyl- 3,8- phenanthridinediammineIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	triphenyltetrazoliumIBA 07/2015
1	Insulin (Novolin)FDA Link 07/2015
1	Diazoxide (Hyperstat)FDA Link 05/2013
1	4,17 beta-dihydroxy-4-androstene-3-oneIBA 05/2013
1	Connexin 43 (Connexin43)IBA 05/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2012
1	Sulfhydryl Compounds (Thiols)IBA 09/2012
1	Deoxyglucose (2 Deoxy D glucose)IBA 10/2009
1	Trypan Blue FDA Link 10/2009
1	Adenosine Triphosphate (ATP)IBA 11/2007
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2007
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 08/2004

Therapy/Procedure

3	Percutaneous Coronary Intervention 07/2021 - 01/2020
2	Therapeutics 01/2021 - 07/2015
1	Catheters 01/2020
1	Microelectrodes 09/2006